kiraya veren Heyecanlanın silindir lancet preprint kıvılcım Doğruyu söylemek gerekirse Araya girmek
For Authors: Submit your work
Robustness of evidence reported in preprints during peer review - The Lancet Global Health
The Lancet Regional Health – Americas
A new paradigm is needed to explain long COVID - The Lancet Respiratory Medicine
Long-term outcomes following hospital admission for COVID-19 versus seasonal influenza: a cohort study - The Lancet Infectious Diseases
The Lancet Commission on lessons for the future from the COVID-19 pandemic - The Lancet
For Authors: Submit your work
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial - The Lancet
For Authors: Submit your work
Preprints with The Lancet: joining online research discussion platforms - The Lancet
Preprints are the future but peer review is still king' - Research Professional News
The Lancet, 06 January 2024, Volume 403, Issue 10421, Pages 1-116, e1
The Lancet Microbe Home Page
Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study - The Lancet Infectious Diseases
For Authors: Submit your work
Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial - The Lancet
First Look - SSRN | Elsevier
A single dose of SARS-CoV-2 FINLAY-FR-1A vaccine enhances neutralization response in COVID-19 convalescents, with a very good safety profile: An open-label phase 1 clinical trial - The Lancet Regional Health – Americas
The Lancet Oncology
Lancet COVID-19 Commission Statement on the occasion of the 75th session of the UN General Assembly - The Lancet
Reporting and data sharing level for COVID-19 vaccine trials: A cross-sectional study - eBioMedicine
The Lancet Global Health Home Page
How swamped preprint servers are blocking bad coronavirus research
Prepublication and clinical practice: challenges ahead
Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: A systematic review - eClinicalMedicine
The Lancet on X: "NEW—Most reliable estimates to date suggest 1 in 8 COVID-19 patients develop #longCOVID symptoms. https://t.co/wechj5flvg https://t.co/pT8lBAWS4g" / X